Ramsay Health Care (ASX:RHC) 3-Year RORE % : -89.66% (As of Dec. 2025)


ASX:RHC Ramsay Health Care Ltd ASX:RHC
87 GF Score
Price A$43.63
GF Value A$50.76
Valuation Modestly Undervalued
! 9 Warning Signs
View Full Analysis

What is Ramsay Health Care 3-Year RORE %?

Ramsay Health Care ASX:RHC +0.23% 87 3-Year RORE % is -89.66 as of Dec. 2025. GuruFocus rates ASX:RHC with a GF Score™ of 87/100 and a GF Value™ of A$50.76 (Modestly Undervalued). The stock has 9 warning signs investors should review. Among 606 Healthcare Providers & Services companies, Ramsay Health Care ranks worse than 90.1% on this metric.

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Ramsay Health Care's 3-Year RORE % for the quarter that ended in Dec. 2025 was -89.66%.

The industry rank for Ramsay Health Care's 3-Year RORE % or its related term are showing as below:

ASX:RHC's 3-Year RORE % is ranked worse than
90.1% of 606 companies
in the Healthcare Providers & Services industry
Industry Median: 0.195 vs ASX:RHC: -89.66

Ramsay Health Care  (ASX:RHC) 3-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Ramsay Health Care 3-Year RORE % Related Terms


Ramsay Health Care 3-Year RORE % Historical Data

* Premium members only.

The historical data trend for Ramsay Health Care's 3-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ramsay Health Care 3-Year RORE % Chart

Ramsay Health Care Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
3-Year RORE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -29.79 -16.80 -50.22 86.63 -40.82

Ramsay Health Care Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
3-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 60.54 86.63 -46.40 -40.82 -89.66

ASX:RHC vs HCA, THC, DVA: 3-Year RORE % Comparison

For the Medical Care Facilities subindustry, Ramsay Health Care's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ramsay Health Care 3-Year RORE % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Ramsay Health Care's 3-Year RORE % distribution charts can be found below:

* The bar in red indicates where Ramsay Health Care's 3-Year RORE % falls into.


ASX:RHC
87GF Score
Ramsay Health Care Ltd ASX:RHC
3-Year RORE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ramsay Health Care 3-Year RORE % Calculation

Ramsay Health Care's 3-Year RORE % for the quarter that ended in Dec. 2025 is calculated as:

3-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 3-year -Cumulative Dividends per Share for 3-year )
=( 1.262-3.699 )/( 5.068-2.35 )
=-2.437/2.718
=-89.66 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Dec. 2025 and 3-year before.

Frequently Asked Questions Learn more about 3-Year RORE % →
What does a 3-Year RORE % of -89.66 mean?
Ramsay Health Care (ASX:RHC) has a 3-Year RORE % of -89.66 as of Dec. 2025. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Ramsay Health Care and its competitors. According to the industry distribution chart, Ramsay Health Care ranks #546 out of 606 companies in the Healthcare Providers & Services industry, placing it in the top 90.1%.
Is Ramsay Health Care's 3-Year RORE % too high?
Ramsay Health Care's current 3-Year RORE % is -89.66. Based on the distribution chart, Ramsay Health Care ranks #546 out of 606 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Ramsay Health Care has a GF Score™ of 87/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ramsay Health Care's 3-Year RORE % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Ramsay Health Care ranks #546 out of 606 companies for 3-Year RORE %. This places Ramsay Health Care in the lower half of its industry. The industry median 3-Year RORE % is 0.20. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Healthcare Providers & Services company?
The median 3-Year RORE % among Healthcare Providers & Services companies is 0.20, based on 606 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year RORE % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Ramsay Health Care and its competitors. For the Healthcare Providers & Services industry, the median 3-Year RORE % is 0.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ramsay Health Care's current 3-Year RORE % is -89.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ramsay Health Care stock overvalued right now?
Based on GuruFocus' analysis, Ramsay Health Care (ASX:RHC) is currently considered Modestly Undervalued. The stock's GF Value™ is A$50.76, compared to a current price of A$43.63 — trading 14% below its estimated fair value. The current 3-Year RORE % is -89.66. Ramsay Health Care's overall GF Score™ is 87/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For Ramsay Health Care (ASX:RHC), the current 3-Year RORE % is -89.66 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ramsay Health Care (ASX:RHC) Overvalued in 2026?

Based on GuruFocus' analysis, Ramsay Health Care stock appears to be undervalued. The current stock price of A$43.63 is trading 14% below its estimated GF Value™ of A$50.76. GuruFocus considers Ramsay Health Care to be Modestly Undervalued.

Key valuation signals for ASX:RHC:

  • 3-Year RORE %: -89.66
  • GF Value™: A$50.76 vs. price of A$43.63 (14% below fair value)
  • GF Score™: 87/100 with 9 warning signs

No single metric tells the full story. See the ASX:RHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ramsay Health Care Business Description

Address 126 Phillip Street, Suite 18.03, Level 18, Deutsche Bank Place, Sydney, NSW, AUS, 2000
Ramsay Health Care is one of the largest private healthcare providers in the world, with more than 500 sites across about eight countries. The key markets in which it operates are Australia, France, the UK, and Sweden. It is the largest private hospital group in each of these markets except for the UK, where it is the largest independent supplier to the NHS. Ramsay Santé, which operates the European regions other than the UK, is a 53%-owned subsidiary of Ramsay Health Care. The company typically earns about two-thirds of consolidated earnings in Australia. Ramsay Health Care undertakes both private and publicly funded healthcare.
87GF Score

Get the complete analysis for ASX:RHC

3-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$43.63
Price
A$50.76
GF Value